Abstract: New platinum(IV) complexes which has a strong antitumor activity and has a feature that a side effect is relatively reduced is provided. The new complex is platinum(IV) complexes with cis,cis-spiro[4,4]nonane-1,6-diamine ligand and is platinum(IV) complexes with optically active cis,cis-spiro[4,4]nonane-1,6-diamine ligand. Especially, the new complex is dichloromalonato((1S,5S,6S)-spiro[4.4]nonane-1,6-diamine)platinum(IV).

Abstract: A new platinum complex which has strong antitumor activity and has effect with smaller doses and a pharmaceutical composition containing the same are provided. A spiro[4,4]nonane-1,6-diamineplatinum(II) complex which is represented by a following general formula (A). (In the formula, X and Y are same or different, and X and Y represent halogen atoms respectively, or X and Y cooperatively represent a divalent residue which is described by a formula (Z).) The platinum complex has a strong antitumor activity and is efficacious as a therapeutic agent for malignant tumors.

Abstract: A semiconductor device includes a gate pad, a gate wiring conductor connected to the gate pad, and a gate electrode formed under the gate pad and the gate wiring conductor. Portions of the gate electrode closer to the gate pad have a higher resistance per unit area than portions of the gate electrode farther away from the gate pad.

Abstract: A liquid crystal display device comprising a liquid crystal display panel, a backlight and a heat sink member is disclosed. The backlight comprises a light-guiding plate disposed on one principal surface side of the liquid crystal display panel, LED light sources disposed on an end surface of the light-guiding plate, a mounting board for mounting the LED light sources thereon and a thermally conductive member connected to the mounting board. The heat sink member is connected to the mounting board through the thermally conductive member.

Abstract: A semiconductor device includes a gate pad, a gate wiring conductor connected to the gate pad, and a gate electrode formed under the gate pad and the gate wiring conductor. Portions of the gate electrode closer to the gate pad have a higher resistance per unit area than portions of the gate electrode farther away from the gate pad.

Abstract: A new platinum complex which has strong antitumor activity and has effect with smaller doses and a pharmaceutical composition containing the same are provided. A spiro[4,4]nonane-1,6-diamineplatinum(II) complex which is represented by a following general formula (A). (In the formula, X and Y are same or different, and X and Y represent halogen atoms respectively, or X and Y cooperatively represent a divalent residue which is described by a formula (Z).) The platinum complex has a strong antitumor activity and is efficacious as a therapeutic agent for malignant tumors.

Abstract: An adhesive agent is uniformly applied to a back surface of a window pane, the application made to an area where a covering member is planned to be adhered and to an area where a positioning fixture and a holding portion are planned to be adhered, the application is also made continuously such that adhesive agent layers of both planned adhesion areas being continuous with an adhesive agent continuous area in between. After that, the window pane and the positioning fixture are set in an injection mold and a polymer material is injected in the mold. This results that the covering member and the holding portion are formed into a shape where they are connected by a connection portion for material flow, which connection portion is formed at a position other than the adhesive agent continuous area. The forming results that the covering member and the holding portion are adhered and fixed to the back surface of the window pane with the adhesive agent layers in between.

Abstract: A liquid crystal display device comprising a liquid crystal display panel, a backlight and a heat sink member is disclosed. The backlight comprises a light-guiding plate disposed on one principal surface side of the liquid crystal display panel, LED light sources disposed on an end surface of the light-guiding plate, a mounting board for mounting the LED light sources thereon and a thermally conductive member connected to the mounting board. The heat sink member is connected to the mounting board through the thermally conductive member.

Abstract: A liquid crystal display device comprising a liquid crystal display panel, a backlight and a heat sink member is disclosed. The backlight comprises a light-guiding plate disposed on one principal surface side of the liquid crystal display panel, LED light sources disposed on an end surface of the light-guiding plate, a mounting board for mounting the LED light sources thereon and a thermally conductive member connected to the mounting board. The heat sink member is connected to the mounting board through the thermally conductive member.

Abstract: A liquid crystal display device comprising a liquid crystal display panel, a backlight and a heat sink member is disclosed. The backlight comprises a light-guiding plate disposed on one principal surface side of the liquid crystal display panel, LED light sources disposed on an end surface of the light-guiding plate, a mounting board for mounting the LED light sources thereon and a thermally conductive member connected to the mounting board. The heat sink member is connected to the mounting board through the thermally conductive member.

Abstract: An adhesive agent is uniformly applied to a back surface of a window pane, the application made to an area where a covering member is planned to be adhered and to an area where a positioning fixture and a holding portion are planned to be adhered, the application is also made continuously such that adhesive agent layers of both planned adhesion areas being continuous with an adhesive agent continuous area in between. After that, the window pane and the positioning fixture are set in an injection mold and a polymer material is injected in the mold. This results that the covering member and the holding portion are formed into a shape where they are connected by a connection portion for material flow, which connection portion is formed at a position other than the adhesive agent continuous area. The forming results that the covering member and the holding portion are adhered and fixed to the back surface of the window pane with the adhesive agent layers in between.

Abstract: A compound represented by the formula or a pharmaceutically acceptable salt thereof wherein R represents an unsubstituted pyridyl, furyl or thienyl group, or a pyridyl, furyl or thienyl group each of which has one or more substituents selected from the group consisting of a hydroxyl group, a lower alkoxy group, a hydroxy lower alkyl group and a hydroxy lower alkenyl group except that when the pyridyl, furyl or thienyl group has a lower alkoxy group as a substituent, each of which simultaneously has another substituent selected from the group consisting of a hydroxyl group, a lower alkoxy group, a hydroxy lower alkyl group and a hydroxy lower alkenyl group, m represents an integer of 1 to 3, and G represents a &bgr;-D-glucopyranosyl group, and the positions of substitution of the hydroxyl groups on the indolopyrrolocarbazole ring are the 1- and 11-positions, or the 2- and 10-positions, and an antitumore agent containing it as an effective ingredient.

Abstract: A cationically polymerizable resin composition which comprises (A) a compound containing at least one ring selected from the group consisting of an oxirane ring and an oxetane ring; (B) an onium salt; (C) an organic peroxide; and (D) an alkaline filler except for a hydroxide.

Abstract: A compound represented by the formula [I] wherein Y1 represents an oxygen atom, or a group represented by NH, O—CO, O—SO2, O—CO—NH, O—CS—NH, NH—CO, NH—SO2, NH—CO—NH or NH—CS—NH, R1 represents an alkyl group, an alkenyl group, an alkynyl group, an aryl group, an aralkyl group, an arylalkenyl group, an arylalkynyl group, a cycloalkyl group, a cycloalkylalkyl group, an alkylcarbonyl group, an alkoxycarbonyl group, an arylcarbonyl group or a heterocyclic group, each optionally having a substituent, or a pharmacologically acceptable salt or ester thereof. The compound shows an excellent antifungal activity on fungi on which existing antifungal agents cannot sufficiently display their effects, and thus is useful as an antifungal agent.

Abstract: The present invention is a process for producing 3-methyl-2-oxoindoline as defined by the following chemical formula (2), including heating of propionylphenylhydrazide as defined by the following chemical formula (1) in the presence of at least one kind of basic calcium compound, characterized in that an organic solvent withstanding at least at a temperature of 180° C. in the presence of the basic calcium compound is employed by at least an amount of equal weight to that of the propionylphenylhydrazide. With the construction mentioned above, even when the amount of calcium oxide is reduced down to as little as 15% of a conventionally used amount, at least 75% of a corresponding yield attained conventionally has been achieved.

Abstract: This invention discloses an adsorbent ideal or the removal of nitrogen oxides (NO.sub.x : nitrogen monoxide and nitrogen dioxide), particularly nitrogen dioxide, from an exhaust gas containing the nitrogen oxides at low concentrations and a method for efficient removal of nitrogen oxides, particularly nitrogen dioxide, from an exhaust gas containing the nitrogen oxides at low concentrations by the use of the adsorbent. The adsorbent either comprises at least one noble metal selected from the group consisting of Pt, Au, Ru, Rh, and Pd and/or a compound thereof supported on a carrier or comprises the noble metal component and an oxide of at least one heavy metal selected from the group consisting of Mn, Fe, Co, Ni, Cu, Zn and Pb, which may be supported on the carrier, if necessary.

Abstract: This invention relates to compounds of the general formula ##STR1## or pharmaceutically salts thereof, wherein R.sup.1 and R.sup.2 each represent an OH group, R.sup.1 is located at the 1- or 2-position, R.sup.2 is located at the 10- or 11-position, R.sup.2 is located at the 11-position when R.sup.1 is located at the 1-position, and R.sup.2 is located at the 10-position when R.sup.1 is located at the 2-position. The compounds of the present invention have an excellent antitumor effect and are hence useful as antitumor agents in the field of medicine.

Abstract: This invention relates to glycosyltransferase, genes encoding glycosyltransferase, recombinant vectors having such a gene, host cells transformed with such a recombinant vector, and uses thereof. This invention makes it possible to glycosylate indolopyrrolocarbazole derivatives conveniently and economically.

Abstract: This invention relates to compounds of the general formula ##STR1## or pharmaceutically salts thereof, wherein R.sup.1 and R.sup.2 each represent an OH group, R.sup.1 is located at the 1- or 2-position, R.sup.2 is located at the 10- or 11-position, R.sup.2 is located at the 11-position when R.sup.1 is located at the 1-position, and R.sup.2 is located at the 10-position when R.sup.1 is located at the 2-position.The compounds of the present invention have an excellent antitumor effect and are hence useful as antitumor agents in the field of medicine.

Abstract: This invention relates to glycosyltransferase, genes encoding glycosyltransferase, recombinant vectors having such a gene, host cells transformed with such a recombinant vector, and uses thereof. This invention makes it possible to glycosylate indolopyrrolocarbazole derivatives conveniently and economically.